Nicole Lambert - Aug 25, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Signature
By: Nathan A. Smith For: Nicole Lambert
Stock symbol
MYGN
Transactions as of
Aug 25, 2021
Transactions value $
-$39,092
Form type
4
Date filed
8/26/2021, 09:55 PM
Previous filing
Aug 5, 2021
Next filing
Aug 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability -$39.1K -1.12K -0.87% $34.81 128K Aug 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021.

Remarks:

Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.